Last reviewed · How we verify
Suppression of Recurrent Herpes Simplex Infection in HIV
Approved treatments
- Valtrex · GSK
Valtrex works by inhibiting the replication of herpes simplex virus DNA through interference with viral DNA polymerase.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Suppression of Recurrent Herpes Simplex Infection in HIV patent landscape — cliff calendar, originator estates, attackable patents
- Suppression of Recurrent Herpes Simplex Infection in HIV treatment landscape brief
- Suppression of Recurrent Herpes Simplex Infection in HIV treatment updates RSS
Frequently asked questions about Suppression of Recurrent Herpes Simplex Infection in HIV
What drugs treat Suppression of Recurrent Herpes Simplex Infection in HIV?
Tracked treatments include Valtrex.
What is the treatment for Suppression of Recurrent Herpes Simplex Infection in HIV?
Standard treatment for Suppression of Recurrent Herpes Simplex Infection in HIV includes Valtrex. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Suppression of Recurrent Herpes Simplex Infection in HIV patent cliff · Suppression of Recurrent Herpes Simplex Infection in HIV CI report
- Treatment: Valtrex · GSK
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing